The BioInnovation Institute was founded in 2017/2018 by the Novo Nordisk Foundation as a life science incubator in Copenhagen, and the scale of backing is extraordinary: a new DKK 5.5B (€736M) allocation for 2026-2035 will double capacity from 20 to 40 startups annually. To date, 131 BII startups have generated 21 products on market, with alumni raising over €1B externally. BII itself has deployed...
London, United Kingdom
Berlin, Germany
Vilnius, Lithuania
Cambridge, United States
Helsinki, Finland
Bristol, United Kingdom